Friday, January 31, 2014

ICT INTRODUCES TWO NEW ELISA BLOCKING BUFFER FORMULATIONS

Proper blocking of the unoccupied areas of ELISA plate wells is paramount to reducing immunoassay background noise and attaining an accurate test result. Two new blocking buffer formulations from ImmunoChemistry Technologies offer additional choices to researchers working to optimize their ELISAs.


Monster Block ELISA Blocking Buffer
Monster Block is a new, non-mammalian blocking buffer
formulation designed to reduce nonspecific binding in
all ELISA formats.
Alternative Block ELISA Blocking Buffer is a new all-synthetic ELISA blocking buffer free of proteins and detergents.

Monster Block Blocking Buffer is a new ELISA blocking buffer utilizing a heterogenous mixture of non-mammalian blocking agents with high blocking strength.

ICT's ELISA Blocking Buffer formulations reduce nonspecific binding of sample and assay components to the ELISA well while stabilizing the coated protein. Six formulations offer benefits to different assay situations:

General Blocker Blocking Buffer BSA-Based
Neptune Block Blocking Buffer Non-Mammalian
Monster Block Blocking Buffer Non-Mammalian
SynBlock Block Blocking Buffer Synthetic
Phosph-Free Block Blocking Buffer Synthetic
Alternative Block Blocking Buffer Synthetic


For economical evaluation of many formulations, ICT offers a Blocking Buffer Optimization Pack (BBOP), which allows researchers to try three different formulations at a reduced rate. Read more about all ELISA Blocking Buffers on Immunochemistry.com: http://www.immunochemistry.com/products/elisa-solutions-1/blocking-buffers.html

ICT offers a large portfolio of tools to improve and enhance ELISA performance, including Blocking Buffers, Wash Buffers, Plate Coating Buffers, Conjugate Stabilizers, Sample Diluents, Substrates, Stop Solutions, and ELISA Plates and Accessories. View our complete portfolio:
ELISA Solutions, Blocking Buffers, and More

Bright Minds, Bright Solutions. ImmunoChemistry Technologies’ mission is to advance scientific discovery by developing innovative products for apoptosis detection, cellular analysis, and immunoassay development.